The World Health Organisation (WHO) has said 3500 lives are lost to viral hepatitis every day, adding that of the 50 million people living with hepatitis C, only 36 per cent had been diagnosed, and 20 per cent have received curative treatment by the end of 2022.
The United Nations health agency’s latest statement on hepatitis C also said it has prequalified the first hepatitis C virus (HCV) self-test which can provide critical support in expanding access to testing and diagnosis, accelerating global efforts to eliminate hepatitis C.
Hepatitis C is an infection caused by a virus that attacks the liver and leads to inflammation.
The report said product, called OraQuick HCV self-test, manufactured by OraSure Technologies, is an extension of the pre-qualified, OraQuick® HCV Rapid Antibody Test which was initially prequalified by WHO in 2017 for professional use, adding that the self-test version, specifically designed for use by lay users, provides individuals with a single kit containing the components that are needed to perform self-test.
“National-level HCVST implementation projects, largely supported by Unitaid, have shown high levels of acceptability and feasibility, as well as empowering people through personal choice, autonomy and access to stigma-free self-care services.” it stated.
READ ALSO: Five Must Do Things For a Successful Career
WHO Director for the Department of Global HIV, Hepatitis and STI Programmes, Dr Meg Doherty said: “Every day 3500 lives are lost to viral hepatitis. Of the 50 million people living with hepatitis C, only 36% had been diagnosed, and 20% have received curative treatment by the end of 2022.
“The addition of this product to the WHO prequalification list provides a safe and effective way to expand HCV testing and treatment services, ensuring more people receive the diagnosis and treatment they need, and ultimately contributing to the global goal of HCV elimination.”
WHO said its prequalification (PQ) programme for in vitro diagnostics (IVDs) evaluates a range of tests, including those used for the detection of antibodies to HCV.
“The programme assesses IVDs against quality, safety and performance standards. It is a cornerstone in supporting countries in achieving high-quality diagnosis and treatment monitoring,” the statement added
WHO Director for the Department of Regulation and Prequalification, Dr Rogério Gaspar said: “The availability of a WHO prequalified HCV self-test enables low- and middle-income countries have access to safe and affordable self-testing options which is essential to achieving the goal of 90% of all people with HCV to be diagnosed.
“This achievement contributes to improving access to quality-assured health products for more people living in low-income countries.”
The post Hepatitis kills 3500 people every day — WHO appeared first on Guardian Nigeria News.
Powered by WPeMatico
